4503
Astellas Pharma Inc
A Tokyo-based pharmaceutical company that researches and develops medicines for cancer, urology, and transplant and immunology care. It was born in 2005 from the merger of two long-standing Japanese drugmakers, Yamanouchi and Fujisawa, which had roots going back to the 1890s. The name "Astellas" blends Latin, Greek, and English words for "star," meant to evoke "aspired stars" and the idea of making tomorrow shine.
ISIN: JP3942400007HealthcareJP1 holder